Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia

This study has been terminated.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals ) Identifier:
First received: March 27, 2012
Last updated: August 26, 2014
Last verified: August 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)